Lampasona V - Search Results

1

HLA-DQ screening for risk assessment of insulin dependent diabetes in northern Italy.

Lampasona V, Ferrari M, Bonifacio E, Pastore MR, Carrera P, Sergi A, Genovese S, Trucco M, Dorman J, Bosi E. Lampasona V, et al. Acta Diabetol. 1995 Oct;32(3):137-42. doi: 10.1007/BF00838481. Acta Diabetol. 1995. PMID: 8590780

2

HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus.

Esposito L, Lampasona V, Bosi E, Poli F, Ferrari M, Bonifacio E. Esposito L, et al. Among authors: lampasona v. Diabetologia. 1995 Aug;38(8):968-74. doi: 10.1007/BF00400587. Diabetologia. 1995. PMID: 7589884

3

Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.

Lampasona V, Bearzatto M, Genovese S, Bosi E, Ferrari M, Bonifacio E. Lampasona V, et al. J Immunol. 1996 Sep 15;157(6):2707-11. J Immunol. 1996. PMID: 8805677

4

Lack of association of DMB polymorphism with insulin-dependent diabetes.

Esposito L, Lampasona V, Bonifacio E, Bosi E, Ferrari M. Esposito L, et al. Among authors: lampasona v. J Autoimmun. 1997 Aug;10(4):395-400. doi: 10.1006/jaut.1997.0144. J Autoimmun. 1997. PMID: 9237803

5

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.

Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, et al. Bonifacio E, et al. Among authors: lampasona v. Diabetologia. 1995 Jul;38(7):816-22. doi: 10.1007/s001250050358. Diabetologia. 1995. PMID: 7556984

6

Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.

Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Bonifacio E, et al. Among authors: lampasona v. J Immunol. 1995 Dec 1;155(11):5419-26. J Immunol. 1995. PMID: 7594559

7

Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen.

Lampasona V, Ferrari M, Bosi E, Pastore MR, Bingley PJ, Bonifacio E. Lampasona V, et al. J Autoimmun. 1994 Oct;7(5):665-74. doi: 10.1006/jaut.1994.1051. J Autoimmun. 1994. PMID: 7840858

8

Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM.

Genovese S, Bonfanti R, Bazzigaluppi E, Lampasona V, Benazzi E, Bosi E, Chiumello G, Bonifacio E. Genovese S, et al. Among authors: lampasona v. Diabetologia. 1996 Oct;39(10):1223-6. doi: 10.1007/BF02658510. Diabetologia. 1996. PMID: 8897011

9

IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.

Bonifacio E, Lampasona V, Bingley PJ. Bonifacio E, et al. Among authors: lampasona v. J Immunol. 1998 Sep 1;161(5):2648-54. J Immunol. 1998. PMID: 9725268

10

Gluten: is it also a determinant of islet autoimmunity?

Bonifacio E, Ziegler AG, Hummel M, Dittler J, Lampasona V, Pastore MR, Bosi E. Bonifacio E, et al. Among authors: lampasona v. Diabetes Metab Rev. 1998 Sep;14(3):258-9. doi: 10.1002/(sici)1099-0895(1998090)14:3<258::aid-dmr221>3.0.co;2-j. Diabetes Metab Rev. 1998. PMID: 9816477 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters